Wednesday, June 4th, 2008
Biofortuna Limited secure proof of concept funding from Merseyside Special Investment Fund and Liverpool Ventures
Biofortuna secures an initial round of funding from the Merseyside Special Investment Fund via Liverpool Ventures.
The Biofortuna team is made up of founder directors Mike Bunce, David Charvill and Ben Passey, previously of Wirral based Invitrogen, formerly Dynal Biotech Ltd.
